Adrien Musuku

Adrien Musuku has a comprehensive work experience in the pharmaceutical industry. Adrien is currently serving as the Chief Scientific Officer at Royalmount Laboratories, a Division of Pharmascience Inc, since January 2020. Prior to that, they held various senior positions at Pharmascience, including Senior Director of Biopharmaceutics and Director of Biopharmaceutics. Adrien also worked at AMU International as the President and Founder, Anapharm as the Bioanalytical Director, Cantest as the Director of Laboratory Operations, and Axelson BioPharma Research as the Director of Laboratory Operations. Overall, Adrien Musuku has extensive experience in biopharmaceutics, bioanalytical development, and laboratory operations.

Adrien Musuku attended the University of Antwerp from 1989 to 1995, where they obtained a Doctor of Science degree in Analytical Chemistry and Toxicology. Adrien also earned a second Doctor of Science degree in Analytical Chemistry during the same period.